Hormone Receptor-Positive and HER2-Positive Breast Cancer: A Medical Update
Featuring Sara Hurvitz, MD, FACP, learn about the use of targeted therapies for early-stage, hormone receptor-positive and HER2-positive breast cancer, explore how these medicines reduce risk of recurrence and how they may be used before and after surgery.
▶︎
Keeping Cancer at Bay: What Researchers Are Learning About Recurrence
▶︎
Updates by subtype: HER2-positive, hormone receptor-positive, and triple-negative MBC
▶︎
Managing anti-estrogen therapy side effects
▶︎
Can a keto diet eliminate cancer growth? Dr. Thomas Seyfried says yes
▶︎
Estrogen Receptors & HER2/neu Receptors in Breast Cancer (a TUTORIAL from Oster Oncology)
▶︎
My Breast Cancer Journey - Part 1 | Invasive Ductal Carcinoma | Karina Style Diaries
▶︎
Nourishing strength: Managing energy and wellness through food
▶︎
Understanding the role of personalized medicine in your cancer journey
▶︎
Ask the expert: Early-stage hormone receptor-positive, HER2-positive & triple-positive breast cancer
▶︎
Understand clinical trials: How to find one and what to expect | Innovations in breast cancer care
▶︎
Ask the expert: Hormone receptor-positive breast cancer
▶︎
Sharing my Her2+ Breast Cancer Diagnosis Story at 35 years old
▶︎
Patient-centered dosing in metastatic breast cancer
▶︎
How to Treat HER2+ Breast Cancer - Discussion with Dr. Sarah Sammons
▶︎
Breast Cancer | Clinical Medicine
▶︎
Christine Handy survived HER2+ breast cancer | mastectomy | herceptin | taxol | lumpectomy | MRSA
▶︎
HER2 Positive Breast Cancer: What's New in Treatment and Research at MBC Patient Forum 2019
▶︎
News flash: Updates from the 2026 ASCO Annual Meeting
▶︎
EVERYTHING you need to know About Herceptin Treatment...
▶︎